Alongside observational and academic studies, we run a range of clinical trials. Please see below the full list of currently open trials and contact details if you are interested in finding out more.


Phase III trial looking at the use of sublingual apomorphine in patients with advanced Parkinson’s Disease. Sponsor: Sunovion.
Currently recruiting. Contact:


Phase II trial looking to examine the efficacy and tolerance of an iron-binding treatment, deferiprone, which reduces the accumulation of iron in the brain, in order to limit the development of Parkinson’s disease. Sponsor: EU. Currently recruiting de novo patients. Contact: